TME 85: The Black Market of Blood Nobody Talks About — And Why It Should Keep You Up at Night

Someone in the world needs blood every two seconds.

Now here is a question most people have never asked: where does that blood actually come from?

The clean, official answer is this — compassionate volunteers walk through hospital doors, roll up their sleeves, and save lives. No money changes hands. Pure altruism.

The real answer is darker.

And it's time we talked about it.

Yes. There Is a Black Market for Blood.

Not in dark alleys. Not only in dystopian fiction.

In real hospitals. In real cities. Right now.

Most people have no idea. And that is exactly how the system — both the formal one and the shadow one — keeps functioning.

The blood black market is one of the most underreported public health crises in the world. Researchers publishing in The Lancet Haematology in 2025 identified illegal blood trade as a significant, under-reported factor that is actively threatening safe blood supply and contributing to preventable maternal and child mortality.

This is a peer-reviewed medical journal calling it out. Not a conspiracy blog.

Here is what it looks like, where it happens, and why it matters to every person who has ever needed a transfusion — or might someday.

Why Does a Black Market for Blood Exist?

The answer is straightforward: demand far outstrips supply.

According to the World Health Organization, approximately 118.5 million blood donations were collected globally in 2023. That sounds large until you realise that 40% of those donations came from high-income countries — which hold a fraction of the world's population. The gap is enormous and is distributed precisely where it hurts most.

In Nigeria, the demand for blood far exceeds the available supply, leaving patients scrambling to find alternatives in ways that are often illegal and always dangerous. The country faces a blood shortfall of over 73% — that is, for every 10 units needed, fewer than 3 are reliably available through safe, formal channels.

In sub-Saharan Africa as a whole, chronic, year-round blood shortages limit the ability of health systems to support patients. An estimated 70% of pregnancy-associated deaths in the world — 287,000 in 2020 — occurred in sub-Saharan African countries, predominantly due to obstetric haemorrhage. Insufficient blood supply directly contributes to this.

In June 2025, England's NHS — one of the most well-funded health systems in the world — issued a "red alert," calling for 200,000 new donors to address critically low blood stock levels.

When legal supply fails, informal supply steps in. It always does. Wherever there is desperate demand and insufficient ethical supply, someone will find a way to profit. Blood is no exception.

How Does the Blood Black Market Actually Work?

The machinery is more sophisticated — and more embedded in the formal system — than most people want to believe.

Level 1: The Professional (Paid) Donor

The most widespread and most tolerated form.

Across many countries where paid donation is either banned or restricted, professional donors persist — people who sell blood repeatedly for cash, operating in plain sight near hospitals, approached by desperate families who have nowhere else to turn.

Severe blood shortages have left patients scrambling to find their own private donors. The unmet demand for blood has spawned a black market in which people donate blood for profit, with few regulations to ensure the blood is free of disease and safe to use.

In Nigeria, middlemen known as "racketeers" broker deals between commercial donors and patients' families. Commercial donors give blood to earn cash and are normally contacted by middlemen. A donor is advised to donate no more than twice a year, but because this practice is illegal, it is not regulated in any way. Many commercial donors donate blood much more frequently than this.

Level 2: The Replacement Donor Trap

Here is where well-intentioned policy unintentionally feeds the market.

Many hospital systems require families to replace blood before — or immediately after — a patient receives a transfusion. The intent is to maintain supply. The outcome is often exploitation.

This system promotes commercial donations from donors who engage in risky lifestyles and increases the risk of transfusion-transmitted infections. The requirement that blood replacements must be found before patients are discharged also puts immense pressure on patients, whose bills from spending extra days in the hospital will continue to accumulate. Many end up turning to social media to appeal for donations and to illegal commercial donors or "racketeers."

The replacement donor system is not a safety valve. It is a funnel into the informal market.

Level 3: The Blood Farm

This is where it stops being uncomfortable and becomes horrifying.

In some settings, blood farms have been documented — operations where vulnerable individuals (poor workers, those with addiction, economic migrants) are recruited under false pretences, bled repeatedly, and discarded when they are too weak to continue.

Blood farms operate at the absolute intersection of human trafficking and healthcare exploitation. They are not hypothetical. They have been investigated and documented by journalists in multiple countries across Asia.

Level 4: Diverted and Stolen Units

Expired units resold. Stolen blood products. Forged compatibility test results. This layer of the market targets specialty products — platelets, fresh frozen plasma, rare blood groups — where legal supply is chronically limited and the financial incentive is highest.

Where legal distribution fails, someone fills the vacuum.

Three Types of Donors — Only One Is Safe

The system often blurs these together. It should not.

Voluntary, Non-Remunerated Donors (VNRD) give blood willingly, without payment, with no personal stake in who receives it. They are the safest donors in the world. They have no financial incentive to conceal their medical history. They donate because they want to.

Replacement (Family) Donors give blood because a relative needs it — under emotional and logistical pressure, often in a short timeframe. They are not necessarily unsafe, but the pressure of the situation, the urgency, and the ease of infiltration by paid proxies make this system inherently vulnerable.

Professional (Paid) Donors are the most dangerous category. Someone who depends on selling blood for income cannot afford to be deferred. They will not disclose a recent high-risk exposure. They will not mention drug use. They will present the history the blood bank wants to hear. Commercial blood donors were mostly young adult males, which unfortunately were also associated with highest carriage rates of transfusion-transmissible infections.

The blood that enters the system through the black market bypasses the most critical safety filter of all: an honest donor.

What Does This Do to Blood Safety?

The damage is real, measurable, and profoundly underreported.

Standard ELISA testing has a window period — the time between infection and detectability — during which a recently infected donor will test negative, but their blood is already infectious. Advanced nucleic acid amplification testing (NAAT) dramatically reduces this window. But many resource-limited settings still rely on ELISA alone, which means the window period remains a live vulnerability every time a high-risk professional donor enters the system.

About 2 million transfusions are given to children annually in sub-Saharan Africa, and at least 200,000 are infected with HIV through blood transfusion. This rate is gradually rising because there is a general lack of interest in voluntarily donating blood, hence blood donation is left to high-risk paid donors.

The black market systematically undermines the entire quality architecture of transfusion medicine:

Screening is bypassed or falsified. Cold chain integrity breaks down when blood moves outside formal channels. Compatibility testing is skipped in some rural settings. Adverse event reporting is nonexistent because the transfusion itself was illegal. Donor health is destroyed by repeat, exploitative donations.

The patient who receives black market blood is not receiving one unit of risk. They are receiving the cumulative risk of every exposure that donor has ever had — disclosed or not.

The Plasma Economy: The Multi-Billion Dollar Problem Nobody Calls a Market

Here is where the story takes a global turn and becomes more morally complex than most people are prepared to discuss.

Plasma and its derivatives represent a large market; the global value was estimated to be $35.8 billion in 2024, and with an 8.5 percent compound annual growth rate, it is projected to reach almost $80 billion by 2034.

Five countries — the United States, Austria, the Czech Republic, Germany, and Hungary — provide 80% of the world's supply. These countries permit paid blood donations. The United States alone supplies approximately 70% of the plasma used worldwide — more in export value than coal and gold combined.

The United States is one of five countries where it's legal to sell plasma, and roughly 20 million people do it every year. "Donating" plasma is low-paid labour that has become essential to an exploitative global medical industry.

The exploitation is structural and deliberate. In countries where donation is voluntary, guidelines usually suggest that donations should only be repeated every two weeks, while in countries where donations are paid, guidelines allow donations as frequently as every two to three days. This hidden form of the "gig economy" targets the most vulnerable, racialised and financially disadvantaged segments of societies.

The geography of plasma tells the full story of who pays the price. Up to 10 percent of plasma collected in the United States "usually comes from Mexican nationals who enter on visitor visas." People crossing an international border specifically to sell the liquid from their veins, because the financial incentive exists only on one side of that border.

Many nations lack plasma self-sufficiency and often rely on the United States, which supplies approximately 70% of the world's plasma. The European Medicines Agency anticipated shortages to affect 14 European countries in 2024.

Think carefully about what this means. The wealthiest nations in the world — with universal healthcare, robust economies, and sophisticated biomedical industries — cannot meet their own plasma needs. They depend on the plasma of people who sell because they have no better financial option.

This is not a black market in the legal sense. But is it ethically clean? That question deserves a serious, honest answer — and it rarely gets one.

What Should Society Know?

Most people believe that when their doctor orders a unit of blood, it came from a kind stranger who volunteered. That image is true in some countries. In many others, it is aspirational fiction.

Here is what society needs to understand plainly:

Blood shortage is not a natural phenomenon. It is the direct result of chronic underinvestment in voluntary donation culture, infrastructure, and policy. The black market fills the gap that we — as a society — have left open.

Replacement donation is not the answer. Systems that require families to replace blood before or after a patient receives it are systems designed, however unintentionally, to create pressure and enable exploitation.

The quality of blood received depends directly on where it came from. A patient who receives blood from a professional donor who concealed a hepatitis infection carries that consequence for life. Blood safety is a direct function of donor selection — and voluntary, non-remunerated donors are the gold standard.

Illegal blood trade is a significant, under-reported factor threatening safe blood supply and contributing to preventable maternal and child mortality. This was said in The Lancet. It deserves the public attention given to far lesser health problems.

Silence is a choice. When communities don't voluntarily donate, someone else fills that gap. Often in ways that harm both the donor and the recipient.

What Can Be Done?

The answer is not complicated. The execution demands sustained will.

Move to 100% voluntary, non-remunerated donation. This is the WHO standard. Countries that have achieved it have both safer blood and more stable supply. The goal is achievable. The political and social will must be built.

Abolish the replacement donation system. It was a stopgap that became a structural trap. It must be phased out — but only once voluntary donation culture is robust enough to replace it. Sequencing matters.

Invest in advanced testing infrastructure. NAAT testing should not be a privilege available only to well-resourced centres. Every blood bank should have the tools to close the window period gap. This requires funding decisions that treat blood safety as a core public health investment, not a cost line to be trimmed.

Enforce what is already law. In many countries, paid donation is already illegal. What is missing is enforcement, traceability, and a hemovigilance infrastructure with actual teeth. Legislation without enforcement is theatre.

Address the plasma equity problem globally. Nations that consume plasma-derived medicines have an ethical obligation to contribute to plasma supply — either through domestic programs with strong protections for donors, or by scaling voluntary plasma programs. Dependence on the economic desperation of others is neither sustainable nor morally defensible.

Build voluntary donation as culture — not as campaign. A one-day blood drive is not a strategy. Culture is built through sustained community engagement, school education, employer programs, religious institution partnerships, and trusted community voices. It takes years. It requires consistency. It is worth every year of effort.

The Way Forward

Blood shortage is not inevitable. It is a choice — made gradually, collectively, through failure to prioritise, failure to educate, failure to build systems that treat blood supply as critical infrastructure.

The blood black market exists because we have not yet built a world where voluntary donation is the norm rather than the exception. It persists because the gap between need and supply is so wide that the informal market becomes functionally essential. And it harms people — donors who are exploited, patients who receive unsafe blood, communities whose trust in healthcare erodes every time a scandal surfaces.

Every country that has achieved a fully voluntary blood supply did so through decades of consistent, community-rooted outreach. They treated blood donation not as a transaction but as a social contract. They invested in donor retention, not just donor recruitment. They built trust, one conversation, one camp, one donor at a time.

Voluntary blood donation is not a medical procedure.

It is a measure of how much a society cares about its most vulnerable members.

A world where no patient dies in need of blood is achievable. But it does not emerge from policy documents and procurement budgets alone.

It begins with culture.

It begins with every one of us choosing — without being paid, without being pressured, without being desperate — to give.